Insider Transactions in Q4 2025 at Ocuphire Pharma, Inc. (OCUP)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2025
|
Cam Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
33,000
+1.69%
|
-
|
|
Dec 29
2025
|
Cam Gallagher |
BUY
Open market or private purchase
|
Indirect |
83,000
+50.0%
|
$83,000
$1.97 P/Share
|
|
Dec 29
2025
|
Cam Gallagher |
BUY
Open market or private purchase
|
Direct |
81,000
+4.11%
|
$81,000
$1.98 P/Share
|
|
Dec 09
2025
|
Foundation Fighting Blindness Retinal Degeneration Fund Director |
SELL
Open market or private sale
|
Direct |
4,000,000
-42.14%
|
$8,000,000
$2.15 P/Share
|
|
Nov 01
2025
|
George Magrath Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
30,350
-2.3%
|
$60,700
$2.3 P/Share
|
|
Oct 22
2025
|
Benjamin R Yerxa President |
SELL
Payment of exercise price or tax liability
|
Direct |
23,795
-6.94%
|
$23,795
$1.95 P/Share
|